BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Zurich
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Copenhagen
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260204
DTEND;VALUE=DATE:20260205
DTSTAMP:20260507T232859
CREATED:20251227T144458Z
LAST-MODIFIED:20251227T144507Z
UID:10000536-1770163200-1770249599@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary cancers: Multimodal Therapy in MIBC: From Established Standard to Future Directions 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Multimodal Therapy in MIBC: From Established Standard to Future Directions 2026 is a technical scientific webinar focused on the evolving treatment landscape of muscle-invasive bladder cancer (MIBC). Scheduled for February 4\, 2026\, this virtual symposium addresses the clinical challenges of MIBC\, which is characterized by high morbidity and mortality. \nOrganized by the European Society for Medical Oncology (ESMO) and chaired by Viktor Gruenwald\, the webinar aims to equip oncology professionals with the skills to critically evaluate emerging data and personalize therapeutic approaches\, including bladder-sparing modalities and biomarker-enabled precision medicine. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-434701
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260205
DTEND;VALUE=DATE:20260207
DTSTAMP:20260507T232859
CREATED:20251126T001629Z
LAST-MODIFIED:20251126T001641Z
UID:10000402-1770249600-1770422399@oncodaily.com
SUMMARY:ESMO Preceptorship on Cervical Cancer 2026: Cape Town
DESCRIPTION:The ESMO Preceptorship on Cervical Cancer 2026: Cape Town is a two-day educational course focusing on providing oncologists with a thorough understanding of cervical cancer management\, including screening\, prevention\, diagnosis\, and the standard of care for early\, locally advanced\, recurrent\, and metastatic disease. The event is scheduled for February 5–6\, 2026\, in Cape Town\, South Africa\, and is accredited with ESMO-MORA category 1 points.
URL:https://oncodaily.com/event/esmo-preceptorship-416466
LOCATION:Cape Town\, South Africa
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260205
DTEND;VALUE=DATE:20260207
DTSTAMP:20260507T232859
CREATED:20260117T221507Z
LAST-MODIFIED:20260117T221516Z
UID:10000591-1770249600-1770422399@oncodaily.com
SUMMARY:Best of ESMO Egypt 2026
DESCRIPTION:The Best of ESMO Egypt 2026 is the fourth edition of the premier oncology review conference in Egypt\, officially licensed by the European Society for Medical Oncology. \nScheduled for February 5–6\, 2026\, at the Hilton Cairo Heliopolis\, the meeting serves as a critical post-congress forum for translating high-level data from the global ESMO meetings into local clinical practice. The program is designed to provide a comprehensive summary of the most practice-changing breakthroughs in medical and radiation oncology\, featuring expert-led analyses of new therapeutic standards and diagnostic advancements. \nRegister.
URL:https://oncodaily.com/event/best-of-esmo-egypt-442506
LOCATION:Hilton Cairo Heliopolis\, El-Orouba\, Sheraton Al Matar\, El Nozha\, Cairo\, 11361\, Egypt
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/Best-of-ESMO-Egypt.webp
ORGANIZER;CN="Arab Organizers":MAILTO:info@araborganizers.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260206
DTEND;VALUE=DATE:20260209
DTSTAMP:20260507T232859
CREATED:20251102T222927Z
LAST-MODIFIED:20251102T222940Z
UID:10000311-1770336000-1770595199@oncodaily.com
SUMMARY:ESMO Summit Africa 2026
DESCRIPTION:The ESMO Summit Africa 2026 is a three-day educational event focused on delivering a summary and contextual review of the most significant cancer treatment advances presented at the previous ESMO annual Congress\, tailored specifically for the oncology community in Africa. Scheduled to take place in Cape Town\, South Africa\, from 6 to 8 February 2026\, the Summit’s main objectives are to review the current standard of care for key malignancies from both a local and international perspective and to discuss current controversies in cancer management. \nYou can find more posts featuring ESMO on OncoDaily.
URL:https://oncodaily.com/event/esmo-summit-africa-402240
LOCATION:Century City Conference Centre\, 4 Energy Lane\, Century City\, Cape Town\, Western Cape\, 7446\, South Africa
ATTACH;FMTTYPE=image/png:https://oncodaily.com/pub/uploads/2025/11/ESMO-Africa.png
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20260209T140000
DTEND;TZID=Europe/Paris:20260209T150000
DTSTAMP:20260507T232859
CREATED:20260126T010719Z
LAST-MODIFIED:20260126T010728Z
UID:10000623-1770645600-1770649200@oncodaily.com
SUMMARY:Pregnancy-Associated Cancer: Clinical Challenges and Ethical Insights
DESCRIPTION:The ESMO Young Oncologists Committee (YOC) will host the next session of the YO4YO Virtual Session Series on Monday\, February 9\, 2026\, from 14:00 to 15:00 CET. This interactive Clinical Case Discussion\, titled “Pregnancy-associated cancer: Clinical challenges and ethical insights\,” is designed to provide young oncologists with a platform to engage with experts on complex clinical scenarios and their associated ethical dilemmas. \nThe session features a distinguished panel\, including Guilherme Nader Marta as the YOC Coordinator\, alongside experts Ann Partridge and Matteo Lambertini\, who will lead the dialogue and offer practical guidance for managing these challenging cases. These virtual sessions aim to foster international collaboration and networking among early-career oncology professionals while addressing specific professional and scientific development needs. \nJoin the session.
URL:https://oncodaily.com/event/pregnancy-associated-cancer-447025
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-6.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:https://esmo-org.zoom.us/j/87294357860?pwd=IHPJamhrV2Ukauh0paWbNjgPrNFKJe.1#success
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260211
DTEND;VALUE=DATE:20260212
DTSTAMP:20260507T232859
CREATED:20251126T120522Z
LAST-MODIFIED:20251126T120536Z
UID:10000406-1770768000-1770854399@oncodaily.com
SUMMARY:RWD and Digital Oncology: EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026
DESCRIPTION:The Real World Data and Digital Oncology webinar\, EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026\, is a virtual event that focuses on the practical application of the ESMO Basic Requirements for AI-based Biomarkers in Oncology (EBAI) framework. \nThe live broadcast date is 11 February 2026 at 18:30 CET. This session will explore how emerging AI-driven biomarkers can be effectively assessed\, validated\, and integrated into clinical decision-making. \nRegister.
URL:https://oncodaily.com/event/digital-oncology-416739
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260212
DTEND;VALUE=DATE:20260214
DTSTAMP:20260507T232859
CREATED:20260128T214419Z
LAST-MODIFIED:20260128T214424Z
UID:10000641-1770854400-1771027199@oncodaily.com
SUMMARY:1st Best of ESMO Levant
DESCRIPTION:The 1st Best of ESMO Levant is scheduled to take place on February 12–13\, 2026\, in Sulaymaniyah\, Iraq. \nOrganized by the Iraqi Society of Clinical Oncology (ISCO) in collaboration with ESMO\, this landmark regional conference is designed to bring the most critical clinical updates and practice-changing research from recent ESMO congresses to the Levant region. \nThe event provides a vital platform for local and international oncology experts to discuss the integration of global standards into regional clinical practice\, focusing on enhancing cancer care delivery through education\, research\, and collaborative innovation.
URL:https://oncodaily.com/event/best-of-esmo-levant-448598
LOCATION:Grand Millennium Hotel Sulaimani\, Sulaymaniyah\, Sulaymaniyah Governorate\, Sulaymaniyah\, 46001\, Iraq
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-11.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260219
DTSTAMP:20260507T232859
CREATED:20251227T145119Z
LAST-MODIFIED:20251227T145133Z
UID:10000537-1771372800-1771459199@oncodaily.com
SUMMARY:ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026
DESCRIPTION:ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026 is a specialized technical webinar scheduled for February 18\, 2026\, focused on the safety profiles and clinical management of next-generation biologics. \nChaired by Elena Garralda\, the program features expert discussions on the molecular mechanisms of on-target/off-tumor effects and evaluates emerging mitigation strategies to optimize patient outcomes. This virtual event\, part of the ESMO Therapeutic Landscapes series\, provides attendees with 1 ESMO-MORA category 1 point and serves as a vital forum for clinicians to refine their expertise in navigating the complexities of modern immunotherapy toxicity. \nRegister.
URL:https://oncodaily.com/event/esmo-therapeutic-landscapes-434705
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Therapeutic-Landscapes.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260218
DTEND;VALUE=DATE:20260220
DTSTAMP:20260507T232859
CREATED:20251126T002120Z
LAST-MODIFIED:20251126T002132Z
UID:10000403-1771372800-1771545599@oncodaily.com
SUMMARY:ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer\, providing oncologists with a thorough understanding of current standards of care\, molecular pathology\, and novel treatment targets. \nThe preceptorship will take place on February 18–19\, 2026\, in Lugano\, Switzerland\, and is accredited with ESMO-MORA category 1 points. Successful applicants receive complimentary course registration and accommodation. The application deadline for this event is December 11\, 2025. \nApply.
URL:https://oncodaily.com/event/esmo-preceptorship-416470
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/esmo-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260225
DTEND;VALUE=DATE:20260226
DTSTAMP:20260507T232859
CREATED:20251126T002352Z
LAST-MODIFIED:20251126T002404Z
UID:10000404-1771977600-1772063999@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the complex management of gastroesophageal cancers using real-world clinical cases. \nThe webinar will be broadcast live virtually on February 25\, 2026\, at 18:30 CET. The discussion will focus on the complexities and evolving areas of practice\, such as optimal biomarker testing\, the integration of immunotherapy\, and the management of treatment-related toxicities. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-416474
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/esmo.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260305
DTSTAMP:20260507T232859
CREATED:20251227T145828Z
LAST-MODIFIED:20251227T145837Z
UID:10000538-1772582400-1772668799@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers : Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026 is a specialized scientific webinar designed to provide an in-depth clinical analysis of the treatment landscape for metastatic urothelial carcinoma (mUC). \nScheduled for March 4\, 2026\, this virtual session focuses on the technical challenges of managing advanced disease where cure is no longer the primary objective\, emphasizing the optimization of medical care through personalized treatment sequencing. This educational event\, chaired by Michiel S. van der Heijden\, is part of the ESMO Deep Dive series\, which utilizes evidence-based data and expert-led discussion to refine clinical decision-making for complex genitourinary oncological cases. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-434709
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Deep-Dive.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260304
DTEND;VALUE=DATE:20260306
DTSTAMP:20260507T232859
CREATED:20251126T003017Z
LAST-MODIFIED:20251126T003058Z
UID:10000405-1772582400-1772755199@oncodaily.com
SUMMARY:ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing\, Selecting\, Treating 2026: Zurich
DESCRIPTION:The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing\, Selecting\, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists\, focusing on using precision medicine to manage patients with HR-positive\, HER2-negative metastatic breast cancer. \nThe event is scheduled to take place on March 4–5\, 2026\, in Zurich\, Switzerland. \nThe application deadline for participation is January 7\, 2026\, at 23:59 CET. The course objectives include understanding the rationale and technical background of biomarker testing\, using results for optimal patient selection\, and discussing the proactive management of precision-medicine-based treatments. \nApply.
URL:https://oncodaily.com/event/breast-cancer-416477
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/esmo-2-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260306
DTEND;VALUE=DATE:20260308
DTSTAMP:20260507T232859
CREATED:20251221T215815Z
LAST-MODIFIED:20251221T215832Z
UID:10000517-1772755200-1772927999@oncodaily.com
SUMMARY:ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich
DESCRIPTION:The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research. \nScheduled for March 6–7\, 2026\, in Zurich\, Switzerland\, the course focuses on multidisciplinary care\, evidence-based management\, and the interpretation of novel translational research\, including molecular profiling and clinical trials. \nLed by co-chairs Viktor Gruenwald and Bernadett Szabados\, the program offers successful applicants complimentary registration\, accommodation\, and a travel grant\, emphasizing ESMO’s commitment to advancing professional expertise in bladder cancer treatment. \nApplication.
URL:https://oncodaily.com/event/esmo-432406
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260311
DTEND;VALUE=DATE:20260314
DTSTAMP:20260507T232859
CREATED:20251126T122443Z
LAST-MODIFIED:20251126T122508Z
UID:10000407-1773187200-1773446399@oncodaily.com
SUMMARY:ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester
DESCRIPTION:The ESMO – The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13\, 2026\, in Manchester\, United Kingdom. \nThe application deadline is January 21\, 2026\, at 23:59 CET\, and the course is accredited for 16 ESMO-MORA category 1 points. \nThe learning objectives cover the full spectrum of thoracic oncology\, from screening and management of early-stage non-small cell lung cancer (NSCLC) to multi-modality treatment for locally advanced disease and systemic therapy for mesothelioma and small-cell lung cancer (SCLC)\, with a focus on advanced treatments like targeted agents for actionable driver mutations\, novel immunotherapies\, and palliative care. \nApply.
URL:https://oncodaily.com/event/esmo-the-christie-preceptorship416745
LOCATION:Manchester\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/ESMO-Christie.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Zurich:20260312T080000
DTEND;TZID=Europe/Zurich:20260314T170000
DTSTAMP:20260507T232859
CREATED:20250710T195346Z
LAST-MODIFIED:20250710T195614Z
UID:10000209-1773302400-1773507600@oncodaily.com
SUMMARY:The ESMO Sarcoma and Rare Cancers Congress 2026
DESCRIPTION:The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano\, Switzerland\, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. \nThe congress will discuss the latest developments in diagnosis\, treatment\, molecular biology\, and classification of sarcomas and other rare cancers. The programme includes a wide range of sessions such as abstract presentations\, educational lectures\, multidisciplinary tumour boards\, guidelines updates\, and dedicated discussions for young oncologists. With opportunities for clinicians\, researchers\, industry professionals\, and patient advocates to connect and collaborate\, the congress promises three days of enriching scientific exchange and community building in the field of rare cancers.
URL:https://oncodaily.com/event/esmo-326996
LOCATION:“Palazzo dei Congressi” in Lugano\, Switzerland\, Piazza Indipendenza 4\, Lugano\, 6900\, Switzerland
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7057.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260316
DTEND;VALUE=DATE:20260319
DTSTAMP:20260507T232859
CREATED:20251114T213627Z
LAST-MODIFIED:20251114T213641Z
UID:10000355-1773619200-1773878399@oncodaily.com
SUMMARY:ESMO Targeted Anticancer Therapies Congress 2026
DESCRIPTION:The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO)\, focused on accelerating the delivery of life-changing anticancer therapies through early drug development. \nThe congress will be held from March 16 to 18\, 2026\, at the Palais des Congrès in Paris\, France. The event serves as a dynamic\, multi-stakeholder meeting\, uniting researchers\, industry leaders\, investors\, and regulators to share new data\, foster collaboration\, and tackle the challenges of advancing early clinical development in oncology. \nElena Garralda\, Carlos Gomez-Roca\, and Cristian Massacesi serve as the co-chairs.
URL:https://oncodaily.com/event/esmo-409793
LOCATION:Palais des Congrès de Paris\, 2 Pl de la Pte Maillot\, Paris\, Île-de-France\, 75017\, France
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7078.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20260319T080000
DTEND;TZID=Europe/Madrid:20260321T170000
DTSTAMP:20260507T232859
CREATED:20250719T103826Z
LAST-MODIFIED:20250801T203138Z
UID:10000223-1773907200-1774112400@oncodaily.com
SUMMARY:The ICHNO 2026
DESCRIPTION:The ICHNO 2026\, the 10th International Congress on Innovative Approaches in Head and Neck Oncology\, will be held from 19–21 March 2026 in Seville\, Spain\, under the theme: “Driven by Biology\, Centred on the Person.”  \nThis unique event—jointly organized by ESTRO\, EHNS\, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the latest advances in head and neck oncology\, grounded in biology and focused on the individual. \nWith global thought leaders\, impactful research\, and opportunities for meaningful dialogue\, ICHNO 2026 will be a vital platform for education\, exchange\, and collaboration. The Chairpersons of the 10th ICHNO Congress are Mererid Evans (ESTRO)\, Giovanni Succo (EHNS)\, and Yungan Tao (ESMO). \nMore posts featuring European Society for Radiotherapy and Oncology on OncoDaily.
URL:https://oncodaily.com/event/the-ichno-2026-332267
LOCATION:Fibes – Conference and Exhibition\, Ave. Alcalde Luis Uruñuela\, 1\, Seville\, 41020\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/08/IMG_7601.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260325
DTEND;VALUE=DATE:20260326
DTSTAMP:20260507T232859
CREATED:20251228T200222Z
LAST-MODIFIED:20251228T200236Z
UID:10000539-1774396800-1774483199@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Endometrial Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Endometrial Cancer 2026 is a specialized virtual scientific meeting scheduled for March 25\, 2026\, focused on the practical application of clinical practice guidelines in the management of endometrial cancer. \nChaired by Ana Oaknin\, the webinar features a multidisciplinary panel of experts who discuss the diagnosis\, staging\, and therapeutic sequencing for endometrial malignancies through the lens of a real-world clinical case. The session provides oncology professionals with 1 ESMO-MORA category 1 point and serves as a forum for translating the latest ESMO Clinical Practice Guidelines into individualized patient care. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-435260
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Copenhagen:20260325T080000
DTEND;TZID=Europe/Copenhagen:20260328T170000
DTSTAMP:20260507T232859
CREATED:20250712T062245Z
LAST-MODIFIED:20250712T062307Z
UID:10000211-1774425600-1774717200@oncodaily.com
SUMMARY:The European Lung Cancer Congress (ELCC 2026)
DESCRIPTION:The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen\, Denmark\, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science\, sharing education\, and enhancing lung cancer care practices globally. \nWith a comprehensive programme designed for medical oncologists\, radiation oncologists\, thoracic surgeons\, respiratory physicians\, interventional radiologists\, and pathologists\, ELCC 2026 offers valuable learning and networking opportunities. Participants are invited to engage in interactive sessions and connect with lung cancer specialists from around the world.
URL:https://oncodaily.com/event/elcc-2026-327158
LOCATION:Bella Center\, Center Boulevard 5\, Copenhagen\, 2300\, Denmark
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7077.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260327
DTEND;VALUE=DATE:20260329
DTSTAMP:20260507T232859
CREATED:20251228T200812Z
LAST-MODIFIED:20251228T200821Z
UID:10000540-1774569600-1774742399@oncodaily.com
SUMMARY:ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing
DESCRIPTION:The ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing is an intensive educational symposium scheduled for March 27–28\, 2026\, in Beijing\, China. \nCo-chaired by Giuseppe Curigliano and Binghe Xu\, this 1.5-day course is specifically designed for experienced oncologists and oncology specialists to deepen their understanding of CDK4/6 inhibition in both early and metastatic HR+/HER2- breast cancer settings. The course is accredited with 11 ESMO-MORA category 1 points\, serving as a vital platform for clinicians in the Asia-Pacific region to integrate the latest evidence into precision breast cancer management. \nApplication.
URL:https://oncodaily.com/event/esmo-advanced-course-435266
LOCATION:Beijing\, China
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-3.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260401
DTEND;VALUE=DATE:20260402
DTSTAMP:20260507T232859
CREATED:20251228T201317Z
LAST-MODIFIED:20251228T201327Z
UID:10000541-1775001600-1775087999@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Renal Cell Carcinoma Frontiers: Innovative Therapies and Precision Diagnostics 2026 webinar\, scheduled for April 1\, 2026\, focuses on the integration of precision diagnostics and innovative therapies in the management of Renal Cell Carcinoma (RCC). \nChaired by Viktor Gruenwald\, the program addresses the clinical challenges of treatment sequencing and patient selection in a rapidly evolving therapeutic landscape. Key sessions cover molecular tailoring for treatment stratification\, the emergence of molecular imaging as a diagnostic and therapeutic tool\, and evidence-based strategies for second-line management of metastatic RCC. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-435270
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-on-Air.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260415
DTEND;VALUE=DATE:20260416
DTSTAMP:20260507T232859
CREATED:20260128T213438Z
LAST-MODIFIED:20260128T213455Z
UID:10000640-1776211200-1776297599@oncodaily.com
SUMMARY:ESMO Therapeutic Landscapes Webinar: Tumour Agnostics 2026
DESCRIPTION:The ESMO Therapeutic Landscapes Webinar: Tumour Agnostics 2026 is a specialized virtual session scheduled for Wednesday\, April 15\, 2026\, from 18:30 to 19:30 CEST. Part of a new educational series designed to keep oncology professionals at the forefront of emerging management strategies\, this webinar focuses on the shift toward treating cancers based on specific molecular alterations rather than their organ of origin. \nThe program aims to explore the latest scientific advances in precision medicine\, highlighting breakthroughs in tumor-agnostic drug development – such as NTRK fusions and microsatellite instability (MSI) – and discussing the practical challenges of integrating these therapies into clinical practice. Participants can earn 1 ESMO-MORA category 1 point for live attendance\, which provides a deeper understanding of the evolving landscape of molecular oncology. \nRegister.
URL:https://oncodaily.com/event/esmo-therapeutic-landscapes-448596
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260415
DTEND;VALUE=DATE:20260417
DTSTAMP:20260507T232859
CREATED:20251126T123548Z
LAST-MODIFIED:20251126T123607Z
UID:10000408-1776211200-1776383999@oncodaily.com
SUMMARY:ESMO Preceptorship on Gastroesophageal Cancer 2026: Bogota
DESCRIPTION:The ESMO Preceptorship on Gastroesophageal Cancer 2026: Bogota is a two-day educational course aimed primarily at oncologists resident in Latin America. It will be held from April 15–16\, 2026\, in Bogota\, Colombia. \nThe application deadline for this preceptorship is February 1\, 2026\, at 23:59 CET. Successful applicants receive complimentary course registration and accommodation\, and a travel grant of up to 800 euros is offered to selected participants. \nApply.
URL:https://oncodaily.com/event/preceptorship-on-gastroesophageal-cancer-416774
LOCATION:Bogota\, Colombia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/11/16_9-2-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260415
DTEND;VALUE=DATE:20260417
DTSTAMP:20260507T232859
CREATED:20251228T201833Z
LAST-MODIFIED:20251228T201844Z
UID:10000542-1776211200-1776383999@oncodaily.com
SUMMARY:ESMO Preceptorship on Breast Cancer 2026: Bogota
DESCRIPTION:The ESMO Preceptorship on Breast Cancer 2026: Bogota is an educational course scheduled for April 15–16\, 2026\, in Bogotá\, Colombia. \nCo-chaired by Carlos Barrios and Nadia Harbeck\, this intensive meeting is primarily aimed at oncologists in Latin America to foster interdisciplinary collaboration and improve subtype-specific breast cancer management. The technical program covers the latest advancements in radiological diagnostics\, neoadjuvant and adjuvant therapies\, and specialized care for young patients and those with advanced disease. \nApplication.
URL:https://oncodaily.com/event/esmo-preceptorship-on-breast-cancer-435278
LOCATION:Bogota\, Colombia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Preceptorship-on-Breast-Cancer-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260417
DTEND;VALUE=DATE:20260419
DTSTAMP:20260507T232859
CREATED:20251228T202535Z
LAST-MODIFIED:20251228T202551Z
UID:10000543-1776384000-1776556799@oncodaily.com
SUMMARY:ESMO Summit Latin America 2026
DESCRIPTION:The ESMO Summit Latin America 2026 is a premier educational meeting scheduled for April 17-18\, 2026\, in Bogotá\, Colombia. \nOrganized by the European Society for Medical Oncology (ESMO) in collaboration with the Colombian Association of Hematology and Oncology (ACHO)\, this two-day summit provides a comprehensive technical review of practice-changing clinical studies and international standards of care. \nThe program is specifically tailored to the regional needs of the Latin American oncology community\, featuring expert-led presentations on key tumor types\, interactive workshops\, and clinical case discussions. Co-chaired by Paula Anel Cabrera-Galeana\, Nadia Harbeck\, and Ray Manneh Kopp\, the event aims to facilitate the integration of the latest oncological breakthroughs into local practice and is typically accredited with ESMO-MORA category-1 CME points. \nRegister.
URL:https://oncodaily.com/event/esmo-summit-latin-america-435283
LOCATION:Hilton Bogota Corferias\, Carrera 37 No. 24 29\, Bogotá\, Bogotá D.C.\, 111321\, Colombia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/ESMO-Latin-America.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260423
DTEND;VALUE=DATE:20260425
DTSTAMP:20260507T232859
CREATED:20260120T145446Z
LAST-MODIFIED:20260120T145452Z
UID:10000603-1776902400-1777075199@oncodaily.com
SUMMARY:ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026: Athens
DESCRIPTION:The ESMO Advanced Course on Early Stage Non-Small-Cell Lung Cancer 2026 is an intensive educational meeting scheduled to take place from April 23–24\, 2026\, in Athens\, Greece. \nUnder the leadership of Co-Chairs Helena Linardou\, Giannis Mountzios\, and Solange Peters\, this course is designed to provide oncology professionals with a comprehensive update on the rapidly evolving diagnostic and therapeutic standards for early-stage NSCLC. \nThe program typically emphasizes multidisciplinary management\, covering advancements in neoadjuvant and adjuvant systemic therapies\, surgical innovations\, and the integration of molecular profiling to personalize patient care. Through a combination of expert lectures and interactive discussions\, the event aims to bridge the gap between clinical trial data and real-world practice to improve outcomes for patients with resectable lung cancer. \nApplication.
URL:https://oncodaily.com/event/esmo-advanced-course-444075
LOCATION:Athens\, Greece
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-NSCLC.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260429
DTEND;VALUE=DATE:20260430
DTSTAMP:20260507T232859
CREATED:20260104T000501Z
LAST-MODIFIED:20260104T000515Z
UID:10000545-1777420800-1777507199@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Bladder Cancer 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Bladder Cancer 2026 is a specialized virtual scientific meeting scheduled for April 29\, 2026\, focused on translating the latest ESMO Clinical Practice Guidelines into clinical practice. \nChaired by Andrea Necchi\, the webinar addresses the rapidly evolving landscape of bladder cancer management\, including the integration of immune checkpoint inhibitors\, antibody–drug conjugates (ADCs)\, and FGFR-targeted therapies. \nThrough a real-world clinical case analysis presented by experts such as Thomas Powles and Ashish Kamat\, the session provides a technical forum for oncology professionals to discuss treatment sequencing\, patient selection\, and the practical implementation of evidence-based standards. Attendees are eligible for 1 ESMO-MORA category 1 point for participating in this interactive educational event. \nRegister.
URL:https://oncodaily.com/event/esmo-guidelines-436359
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260506
DTEND;VALUE=DATE:20260507
DTSTAMP:20260507T232859
CREATED:20260104T000937Z
LAST-MODIFIED:20260104T000945Z
UID:10000546-1778025600-1778111999@oncodaily.com
SUMMARY:ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Genitourinary Cancers: Improving Outcomes in High-Risk Localized Prostate Cancer 2026 is a virtual scientific webinar scheduled for May 6\, 2026. \nThis session focuses on the clinical management of high-risk localized prostate cancer\, a disease state associated with significant risks of recurrence and mortality. Chaired by Deborah Mukherji\, the program features technical discussions led by experts including Stephen Freedland\, Christopher Sweeney\, and Derya Tilki. \nKey topics include advanced risk stratification\, the role of systemic therapies in combination with radiotherapy\, and evidence-based strategies for managing biochemical recurrence. The webinar aims to provide oncology professionals with updated knowledge to individualize treatment approaches and improve long-term outcomes\, awarding 2 ESMO-MORA category 1 points to live participants. \nRegister.
URL:https://oncodaily.com/event/esmo-deep-dive-436363
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Deep-Dive.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20260506T080000
DTEND;TZID=Europe/Berlin:20260508T170000
DTSTAMP:20260507T232859
CREATED:20250712T062036Z
LAST-MODIFIED:20250712T062110Z
UID:10000212-1778054400-1778259600@oncodaily.com
SUMMARY:The ESMO Breast Cancer 2026
DESCRIPTION:Join the global breast cancer community at ESMO Breast Cancer 2026\, taking place from 6 to 8 May 2026 in Berlin\, Germany\, or online. \nThis international congress will gather top experts\, researchers\, and clinicians to explore the latest advances in breast cancer care\, covering everything from early detection to innovative treatments and survivorship strategies. \nThe event offers a platform to engage with global leaders\, share real-world insights\, and help shape the future of breast cancer treatment. The Scientific Committee is co-chaired by Masakazu Toi\, Sara Tolaney and Nicholas Turner.
URL:https://oncodaily.com/event/esmo-327164
LOCATION:Messe Berlin\, Messedamm 22\, Berlin\, 14055\, Germany
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/07/IMG_7076.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260513
DTSTAMP:20260507T232859
CREATED:20260104T001332Z
LAST-MODIFIED:20260104T001344Z
UID:10000547-1778457600-1778630399@oncodaily.com
SUMMARY:ESMO Preceptorship on Hereditary Cancer Genetics 2026: Lugano
DESCRIPTION:The ESMO Preceptorship on Hereditary Cancer Genetics 2026 is an intensive educational course scheduled for May 11–12\, 2026\, in Lugano\, Switzerland. \nCo-chaired by Judith Balmaña and Marjolijn Ligtenberg\, this program is designed to provide oncologists with a comprehensive understanding of the molecular basis of genetic susceptibility to cancer. The technical curriculum focuses on the multidisciplinary management of hereditary cancer syndromes\, the identification and diagnosis of germline genetic mutations\, and the implementation of evidence-based prevention strategies. \nThrough a combination of state-of-the-art lectures and interactive clinical case discussions\, the course aims to equip participants with the skills necessary to provide personalized care for patients with hereditary cancer risks. Successful applicants benefit from complimentary registration and accommodation\, and the event is accredited with 9 ESMO-MORA category 1 points. \nApplication.
URL:https://oncodaily.com/event/hereditary-cancer-genetics-436366
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/ESMO-Preceptorship.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR